A specific sequence of therapies can improve outcomes for patients with some aggressive forms of lymphoma, according to a new study.
Reporting in the British Journal of 91»ÆÍø, researchers report using a range of techniques to identify an alt...
1 month ago
Spanish researchers have unveiled a new CAR-T cell therapy which offers promise for treating Hodgkin’s disease and other refractory CD30+ lymphomas.
The treatment targets the CD30 protein and a phase I trial has found improved clinical outcomes in...
1 month ago
